D&Mカンパニー announced its policy of publishing the investment asset balance for the fiscal year ending August 2026 on a monthly basis, along with the balance as of August. The number of companies whose receivables it purchased reached 101, while the investment asset balance rose ¥997 million month on month to ¥10,603 million, exceeding ¥10 billion for the first time since founding.
The investment asset balance for the fiscal year ending August 2026 increased ¥997 million from the end of the previous month to ¥10,603 million, mainly due to the acquisition of business land to be leased under fixed-term leases to medical corporations, among other factors. The number of companies whose receivables it purchased remained unchanged at 101 from the end of July, with 2 new companies added and 2 cancellations.
D&M Group provides multiple services in combination to medical and nursing care operators, and its Finance & Investment (F&I) services are positioned as a foundation for business growth, with a high proportion of net sales. Fee income from the purchase of medical and long-term care reimbursement receivables accounts for most of sales, and the investment asset balance is regarded as an important indicator of business expansion.
This press release was issued as part of the company's policy of publishing its investment asset balance monthly and is understood to form part of its management strategy based on one-stop support for medical, nursing care and welfare services.